Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

BIT:DEX - Euronext Milan - IT0005543480 - Common Stock - Currency: EUR

6.88  +0.12 (+1.78%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DEX. DEX was compared to 31 industry peers in the Household Durables industry. DEX has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on DEX.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year DEX was profitable.
In the past year DEX had a positive cash flow from operations.
DEX had positive earnings in 4 of the past 5 years.
DEX had a positive operating cash flow in each of the past 5 years.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

With a decent Return On Assets value of 4.04%, DEX is doing good in the industry, outperforming 74.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.92%, DEX is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
DEX has a better Return On Invested Capital (7.68%) than 67.74% of its industry peers.
DEX had an Average Return On Invested Capital over the past 3 years of 7.89%. This is significantly below the industry average of 16.03%.
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROIC 7.68%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

DEX has a Profit Margin of 3.83%. This is in the better half of the industry: DEX outperforms 61.29% of its industry peers.
DEX's Profit Margin has declined in the last couple of years.
DEX has a Operating Margin (7.13%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DEX has declined.
Looking at the Gross Margin, with a value of 39.27%, DEX is in line with its industry, outperforming 45.16% of the companies in the same industry.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DEX is creating some value.
DEX has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for DEX has been reduced compared to a year ago.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

DEX has an Altman-Z score of 1.96. This is not the best score and indicates that DEX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, DEX is in line with its industry, outperforming 48.39% of the companies in the same industry.
DEX has a debt to FCF ratio of 4.55. This is a neutral value as DEX would need 4.55 years to pay back of all of its debts.
DEX has a Debt to FCF ratio of 4.55. This is in the better half of the industry: DEX outperforms 70.97% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that DEX is not too dependend on debt financing.
DEX's Debt to Equity ratio of 0.38 is in line compared to the rest of the industry. DEX outperforms 54.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Altman-Z 1.96
ROIC/WACC1.17
WACC6.56%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.12 indicates that DEX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, DEX is doing worse than 70.97% of the companies in the same industry.
DEX has a Quick Ratio of 1.12. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, DEX is in line with its industry, outperforming 45.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.81
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for DEX have decreased strongly by -44.20% in the last year.
DEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
The Revenue has grown by 12.85% in the past year. This is quite good.
Measured over the past years, DEX shows a very strong growth in Revenue. The Revenue has been growing by 31.04% on average per year.
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%

3.2 Future

Based on estimates for the next years, DEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.44% on average per year.
DEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.56% yearly.
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue Next Year4.98%
Revenue Next 2Y5.09%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

DEX is valuated reasonably with a Price/Earnings ratio of 10.42.
Based on the Price/Earnings ratio, DEX is valued a bit cheaper than 67.74% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, DEX is valued rather cheaply.
A Price/Forward Earnings ratio of 6.40 indicates a rather cheap valuation of DEX.
DEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. DEX is cheaper than 83.87% of the companies in the same industry.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.42
Fwd PE 6.4
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DEX is cheaper than 80.65% of the companies in the same industry.
DEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DEX is cheaper than 74.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.08
EV/EBITDA 3.76
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

DEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y12.08%
EPS Next 3Y8.44%

More info and screens

0

5. Dividend

5.1 Amount

DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEXELANCE SPA

BIT:DEX (7/11/2025, 7:00:00 PM)

6.88

+0.12 (+1.78%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.93%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap185.28M
Analysts88.57
Price Target12.17 (76.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.14%
PT rev (3m)-9.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 10.42
Fwd PE 6.4
P/S 0.39
P/FCF 9.08
P/OCF 7.32
P/B 1.11
P/tB N/A
EV/EBITDA 3.76
EPS(TTM)0.66
EY9.59%
EPS(NY)1.07
Fwd EY15.62%
FCF(TTM)0.76
FCFY11.01%
OCF(TTM)0.94
OCFY13.66%
SpS17.72
BVpS6.21
TBVpS-2.46
PEG (NY)0.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROCE 10.57%
ROIC 7.68%
ROICexc 8.82%
ROICexgc 52.73%
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
FCFM 4.27%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Debt/EBITDA 1.11
Cap/Depr 21.25%
Cap/Sales 1.03%
Interest Coverage 250
Cash Conversion 44.3%
Profit Quality 111.6%
Current Ratio 1.12
Quick Ratio 0.81
Altman-Z 1.96
F-Score7
WACC6.56%
ROIC/WACC1.17
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%
Revenue Next Year4.98%
Revenue Next 2Y5.09%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y-22.63%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year47.8%
EBIT Next 3Y13.65%
EBIT Next 5YN/A
FCF growth 1Y157.29%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y97.69%
OCF growth 3Y11.3%
OCF growth 5YN/A